Luye Medical Considers Sale of Oncology Business in Singapore, Sources Say

España Noticias Noticias

Luye Medical Considers Sale of Oncology Business in Singapore, Sources Say
España Últimas Noticias,España Titulares

Luye Medical Group is weighing a sale of its oncology business in Singapore, people with knowledge of the matter said, potentially adding to a wave of health-care deals in the region.

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Cathie Wood’s Ark Buys Rize ETF in Big Bet on European GrowthJanus Henderson Is Dominating the CLO ETF MarketAirline Stocks Tumble Into Bear Market on Soaring Oil PricesCathie Wood, Boaz Weinstein Among Winners From Bitcoin Fund BetZero-Day Options Boom Is Spilling Into $7.

4 Trillion ETF MarketFund Managers See Water Risk in Semiconductor Bets Being MispricedFranklin Templeton Joins Race to Offer US Spot Bitcoin ETFFear of Stock Market Dive Creeps Back as Hedging Costs ClimbNomura Crypto Chief Warns Market Rout May Delay Unit’s ProfitTelevision deals, ratings generate record-setting NFL revenueAwareness still at disadvantage in decades-long battle for tennis pay equityCorporations considering Canadian cricketCurling Canada announces Montana’s as new sponsor of...

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

BNNBloomberg /  🏆 83. in ES
 

España Últimas Noticias, España Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Bankrupt drugmaker Mallinckrodt considers sale of opioid businessBankrupt drugmaker Mallinckrodt considers sale of opioid businessSome investors, poised to take control through the company's ongoing bankruptcy proceedings, are suggesting Mallinckrodt break up its business units, the report said. Mallinckrodt did not immediately respond to a Reuters request for comment. The Ireland-based company filed for its second bankruptcy in the United States last month, with a restructuring plan that would cut $1 billion from what it owes to victims of the U.S. opioid crisis.
Leer más »

Bankrupt drugmaker Mallinckrodt considers sale of opioid businessBankrupt drugmaker Mallinckrodt considers sale of opioid business(Reuters) - Bankrupt drugmaker Mallinckrodt is in talks with major investors about selling some or all of its business units, which could lead to its ...
Leer más »

EU antitrust regulators raid cardiovascular medical device companyEU antitrust regulators raid cardiovascular medical device companyBRUSSELS (Reuters) - EU antitrust regulators on Tuesday raided a cardiovascular medical device company in an EU country on concerns that the company ...
Leer más »



Render Time: 2025-01-21 09:37:32